Theravance Biopharma (NASDAQ: TBPH) today announced that it has submitted an investigational new drug (IND) application to the U.S. Food ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE